Pharmocann Global Ltd. Logo

Pharmocann Global Ltd.

Researches, cultivates, and produces medical-grade cannabis and hemp products.

PMCN-M | TA

Overview

Corporate Details

ISIN(s):
IL0010968902
LEI:
Country:
Israel
Address:
Horesh Haalonim 1, 3009500 Ramat Yishai

Description

Pharmocann Global Ltd. is a company specializing in the research, cultivation, production, and distribution of medical-grade cannabis products. Its product portfolio includes various formulations such as oils, ointments, tablets, and inhalers designed for medical applications. The company emphasizes a pharmaceutical approach, adhering to Good Manufacturing Practices (GMP) to create standardized and validated cannabis-based medicines. It operates its own cultivation facilities, including research and development greenhouses, and collaborates with research institutions to advance its product development. The company also produces and distributes hemp-based cosmetic and seed oil products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-04 19:38
The sector classification of BLUE WAVE WATER CAPITAL will be changed, as of Au…
English 99.3 KB
2025-02-17 18:43
Changes in the company's name and security, effective as of February 19, 2025
Hebrew (modern) 118.3 KB
2023-10-03 16:36
Excellence will cease to operate as a market maker in the company's shares as o…
Hebrew (modern) 118.8 KB
2020-08-23 11:39
Investors Presentation - August 2020
English 20.2 MB
2020-08-23 11:39
Investors Presentation - August 2020
Russian 42.3 KB

Automate Your Workflow. Get a real-time feed of all Pharmocann Global Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pharmocann Global Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pharmocann Global Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.